This inventor holds 6 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: Nps Pharmaceuticals, Inc., Myrexis, Inc., Myriad Pharmaceuticals, Inc.. Active years: 1999-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 93 
1 out of 12 
1 out of 4 Years Active: 1999-2013
Title: Richard Trovato: Innovator in Cancer Therapeutics
Introduction
Richard Trovato is a prominent inventor based in Salt Lake City, UT (US), known for his significant contributions to the field of cancer therapeutics. With a total of six patents to his name, Trovato has focused on developing innovative compounds that target critical pathways in cancer treatment.
Latest Patents
Among his latest patents, Trovato has developed purine-core inhibitors of HSP90, which are compounds designed to treat cancer. These compounds are characterized by specific formulae, where A can be a substituted or unsubstituted aryl, heteroaryl, heterocyclic, or carbocyclic group. Additionally, B can be a substituted or unsubstituted piperidine, homopiperidine, piperazine, pyrrolidine, or azetidine group. The compounds also include various substituents such as hydro, alkyl, aryl, heteroaryl, amino, or halo. Another notable patent involves therapeutic compounds that utilize similar structural elements for cancer treatment.
Career Highlights
Trovato has had a distinguished career, working with notable companies such as NPS Pharmaceuticals, Inc. and Myriad Pharmaceuticals, Inc. His work in these organizations has contributed to advancements in pharmaceutical research and development, particularly in oncology.
Collaborations
Throughout his career, Trovato has collaborated with
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile